Similarly, an association between the expression of ErbB4 and a favourable clinical outcome has been reported in some clinical studies [41,45,48,49], whilst other researchers have suggested that ErbB4 expression might be a marker of a poorer outcome in some breast cancer patients [43,50]. Here, ERBB4 is linked to breast cancer.